|
1
|
Jusu MO, Glauser G, Seward JF, Bawoh M, Tempel J, Friend M, Littlefield D, Lahai M, Jalloh HM, Sesay AB, Caulker AF, Samai M, Thomas V, Farrell N, Widdowson MA. Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone. J Infect Dis 2019; 217:S48-S55. [PMID: 29788339 DOI: 10.1093/infdis/jix336] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Clinical Trials Registration ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].
Collapse
Affiliation(s)
- Morrison O Jusu
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | | | - Jane F Seward
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Mohamed Bawoh
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | | | - Michael Friend
- Global Good, Intellectual Ventures, Bellevue, Washington
| | | | - Michael Lahai
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | - Hassan M Jalloh
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | - Amara Bangali Sesay
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | - Amanda F Caulker
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | - Mohamed Samai
- College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
| | - Vasavi Thomas
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | | | | |
Collapse
|
|
2
|
Leendertz SAJ, Wich SA, Ancrenaz M, Bergl RA, Gonder MK, Humle T, Leendertz FH. Ebola in great apes - current knowledge, possibilities for vaccination, and implications for conservation and human health. Mamm Rev 2016. [DOI: 10.1111/mam.12082] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Siv Aina J. Leendertz
- Great Apes Survival Partnership (GRASP); United Nations Environment Programme; P.O. Box 30552 Nairobi Kenya
- Research Group Epidemiology of Highly Pathogenic Microorganisms; Robert Koch-Institute; Seestrasse 10 13353 Berlin Germany
| | - Serge A. Wich
- Liverpool John Moore's University; 70 Mount Pleasant; Liverpool L3 5UA Merseyside UK
| | - Marc Ancrenaz
- Borneo Futures; Taman Kinanty, Lorong Angsa 12, House 61D 88300 Kota Kinabalu Sabah Malaysia
| | - Richard A. Bergl
- North Carolina Zoo; 4401 Zoo Parkway Asheboro North Carolina USA
| | - Mary K. Gonder
- Department of Biology; Drexel University; 3245 Chestnut Street Philadelphia PA 19104 USA
| | - Tatyana Humle
- Durrell Institute of Conservation and Ecology; School of Anthropology and Conservation; University of Kent; Canterbury CT2 7NR UK
| | - Fabian H. Leendertz
- Research Group Epidemiology of Highly Pathogenic Microorganisms; Robert Koch-Institute; Seestrasse 10 13353 Berlin Germany
| |
Collapse
|
|
3
|
Abstract
The unprecedented dimensions of the 2014 Ebola epidemic which ravaged 3 West African countries have challenged public health response capacity and urged the availability of safe and effective vaccines. In this context, vectored vaccines already tested in animal models have undergone phase 1 studies in human beings and are now ready for efficacy evaluation in large scale trials. Health care workers and other frontline caregivers are likely to be the target population for both vaccine trials and vaccination campaigns. However, methodological and ethical issues should be considered in plans concerning the conduction of clinical trials and the possible use of licensed vaccines against Ebola.
Collapse
Affiliation(s)
- Giovanni Rezza
- a Department of Infectious, Parasitic, and Immunomediated Diseases; Istituto Superiore di Sanità ; Roma , Italy
| |
Collapse
|